Determination of prognostic factors in 18F-FDG PET/CT of relapsed/refractory Hodgkin lymphoma

被引：0
作者：
Jajroudi, M. [1 ]
Geramifar, P. [2 ]
Eslami, S. [1 ,3 ]
机构：
[1] Mashhad Univ Med Sci, Pharmaceut Res Ctr, Med Informat, Mashhad, Iran
[2] Univ Tehran Med Sci, Res Ctr Nucl Med, Nucl Med, Tehran, Iran
[3] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Med Informat, Amsterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-2121
引用
收藏
页码：S1908 / S1909
页数：2
相关论文
共 50 条
  • [41] THE PROGNOSTIC IMPACT OF 18F-FDG PET/CT IN LYMPHOMA PATIENTS AFTER STANDARD CHEMOTHERAPY
    Mladenov, K.
    Spassov, B.
    Hadzhiyska, V.
    Vassileva, D.
    HAEMATOLOGICA, 2017, 102 : 746 - 746
  • [42] Prognostic value of metabolic criteria with 18F-FDG PET / CT in patients with follicular lymphoma
    Cozar Santiago, M.
    Garcia Garzon, J.
    Soler Peter, M.
    Igua Saenz, C.
    Sanz Llorens, R.
    Sanchez-Jurado, R.
    Aguilar Barrios, J.
    Faus Rodrigo, V.
    Riera Gil, E.
    Ferrer Rebolleda, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S724 - S725
  • [43] Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma
    Albano, Domenico
    Bosio, Giovanni
    Pagani, Chiara
    Re, Alessandro
    Tucci, Alessandra
    Giubbini, Raffaele
    Bertagna, Francesco
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (01) : 87 - 96
  • [44] 18f-FDG PET-CT Assessment of Responses to Salvage Therapy and Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Classical Hodgkin Lymphoma (cHL)
    Tatarczuch, Maciej
    Hildyard, Catherine
    Subesinghe, Manil
    Eyre, Toby A.
    Collins, Graham
    BLOOD, 2017, 130
  • [45] The role of 18F-FDG PET/CT in the change of staging and therapeutic management in patients with Hodgkin Lymphoma
    Asabella, A. Niccoli
    Montemurro, I.
    Pisciotta, N.
    Rubini, D.
    Lauriero, F.
    Rubini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (SUPPL 2) : 241 - 241
  • [46] 18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract
    Tempescul, Adrian
    Querellou, Solene
    Ianotto, Jean-Christophe
    Boisrame, Sylvie
    Valette, Gerald
    Berthou, Christian
    ANNALS OF HEMATOLOGY, 2010, 89 (06) : 635 - 637
  • [47] Prognostic value of 18F-FDG PET/CT based on IMPeTUs in patients with relapsed multiple myeloma
    Guo, Yuehong
    Huang, Jingwei
    Wang, Li
    Liu, Aijun
    Yang, Min-Fu
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [48] PET/CT in the Evaluation of Relapsed or Refractory Hodgkin Lymphoma
    Jauhari, Shekeab
    Nasta, Sunita D.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (09) : 8 - 13
  • [49] Prognostic value of baseline 18F-FDG PET/CT metabolic parameters in paediatric lymphoma
    Zhou, Yeye
    Hong, Zhihui
    Zhou, Min
    Sang, Shibiao
    Zhang, Bin
    Li, Jihui
    Li, Qingru
    Wu, Yiwei
    Deng, Shengming
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2020, 64 (01) : 87 - 95
  • [50] 18F-FDG PET/CT for response assessment in Hodgkin lymphoma undergoing immunotherapy with checkpoint inhibitors
    Castello, Angelo
    Grizzi, Fabio
    Qehajaj, Dorina
    Rahal, Daoud
    Lutman, Fabio
    Lopci, Egesta
    LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 367 - 375
12345